Form 8-K - Current report:
SEC Accession No. 0001193125-22-294492
Filing Date
2022-11-30
Accepted
2022-11-29 18:04:02
Documents
13
Period of Report
2022-11-29
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d384864d8k.htm   iXBRL 8-K 24361
2 EX-99.1 d384864dex991.htm EX-99.1 5742
  Complete submission text file 0001193125-22-294492.txt   152943

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bhc-20221129.xsd EX-101.SCH 2521
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bhc-20221129_lab.xml EX-101.LAB 17940
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bhc-20221129_pre.xml EX-101.PRE 11231
7 EXTRACTED XBRL INSTANCE DOCUMENT d384864d8k_htm.xml XML 3447
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Filer) CIK: 0000885590 (see all company filings)

EIN.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 221433841
SIC: 2834 Pharmaceutical Preparations